Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas [NA]
This clinical trial update reports on a brief intervention to improve medication knowledge and adherence among family medicine patients in S…
-
FDA approval · 2015-10-06FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries Inc.)
The FDA approved a supplemental application for atorvastatin calcium from Sun Pharmaceutical Industries Inc., granting regulatory approval f…
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Lean Seafood Intake and Postprandial Metabolism [NA]
A completed clinical trial evaluated the effects of lean seafood intake on postprandial metabolism, including lipid and glucose responses. T…
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels [Phase 2]
Phase 2 trial update on a monoclonal antibody targeting PCSK9 to lower LDL-C in adults not on lipid therapy; study completed with results po…
-
CLINICAL_TRIALS trial_result · 2015-10-01Clinical Trial Update: LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy [Phase 2]
Phase 2 trial update investigating PCSK9 monoclonal antibody with statin therapy for lowering LDL cholesterol in hyperlipidemia, results pos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Telephone Based Management of Hyperlipidemia [Phase 4]
Phase 4 clinical trial results for telephone-based management of hyperlipidemia have been posted. The study is completed and results were po…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of HL-040XC for essential hypertension and hyperlipidemia has completed; results a…
-
CLINICAL_TRIALS trial_result · 2015-09-16Clinical Trial Update: Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of HCP1105 in combined hyperlipidemia patients at high risk for coronary heart dis…
-
FDA approval · 2015-09-16FDA Approved: GEMFIBROZIL — Original Application (NorthStar Rx LLC)
FDA approved an original ANDA for a generic gemfibrozil product manufactured by NorthStar Rx LLC.
-
FDA approval · 2015-09-15FDA Approved: GEMFIBROZIL — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for Gemfibrozil under Northstar RxLLC's ANDA, authorizing changes to the approved product.
-
CLINICAL_TRIALS withdrawal · 2015-09-10Clinical Trial Update: Genomic Dissection of a QTL Affecting the Lipid Profile
A clinical trial update indicates that the study examining a quantitative trait locus affecting lipid metabolism has been withdrawn.
-
FDA approval · 2015-08-31FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' Supplemental NDA for fenofibrate, authorizing approved changes to this lipid-lowering medicine. This act…
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: Veterans Walk for Health Study [NA]
The Veterans Walk for Health Study has completed, but the update does not provide results.
-
FDA approval · 2015-08-17FDA Approved: FENOFIBRATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin's original application for fenofibrate (generic fenofibrate), expanding access to a lipid-lowering option.
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia [Phase 2]
The document reports the completion status of a Phase 2 pilot study evaluating CAT-2003 in patients with severe hypertriglyceridemia.
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Gender Dependent Difference in Lipemia After 6 x OFTT in Young Healthy Subjects [NA]
The completed clinical trial reports a gender-dependent difference in lipemia after six oral fat tolerance tests in young healthy subjects. …
-
FDA approval · 2015-07-09FDA Approved: NIACIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for NIACIN (nicotinic acid) from Sun Pharmaceutical Industries, Inc., relating to an additional appr…
-
FDA approval · 2015-07-09FDA Approved: NIACIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' supplemental application for NIACIN (nicotinic acid).
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia [Phase 4]
A Phase 4 clinical trial comparing Cresnon and Crestor in patients with hyperlipidemia has completed, evaluating efficacy and safety.
-
FDA approval · 2015-06-26FDA Approved: EZETIMIBE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved the original application for ezetimibe (generic) by Glenmark Pharmaceuticals Inc., USA.
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration [Phase 2]
Phase 2 clinical trial update evaluating mipomersen (ISIS 301012) and its effect on liver fat content in lipid metabolism disorders and hype…
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol [Phase 2]
Phase 2 trial updates on the safety and potential benefit of MBX-8025, with and without concurrent statin therapy, in moderately overweight …
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Effect of Fenofibrate Conversion on Triglyceride Levels in Patients on Statin Therapy [NA]
This clinical trial assessed whether converting to fenofibrate affects triglyceride levels in patients already taking statins; results were …
-
FDA approval · 2015-06-01FDA Approved: CRESTOR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for CRESTOR (rosuvastatin) submitted by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: The Medicines Advice Service Evaluation [NA]
A completed evaluation of the Medicines Advice Service at University College London, focusing on Type 2 diabetes mellitus and hyperlipidemia…